Rezolute, Inc. financial data

Symbol
RZLT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Shoreline Drive, Suite 500, Redwood City, CA
State of incorporation
NV
Fiscal year end
June 30
Former names
AntriaBio, Inc. (to 12/7/2017), FITS MY STYLE INC (to 1/11/2013)
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.19K % -27.7%
Debt-to-equity 12.6 % +61.2%
Return On Equity -70.3 % -35.7%
Return On Assets -62.5 % -29.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60.5M shares +52.8%
Common Stock, Shares, Outstanding 60.5M shares +52.8%
Entity Public Float 33.3M USD -47.7%
Common Stock, Value, Issued 61K USD +52.5%
Weighted Average Number of Shares Outstanding, Basic 69.9M shares +36%
Weighted Average Number of Shares Outstanding, Diluted 69.9M shares +36%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 56.9M USD +15.1%
General and Administrative Expense 16.5M USD +26%
Operating Income (Loss) -73.3M USD -17.4%
Nonoperating Income (Expense) 2.2M USD -61.1%
Net Income (Loss) Attributable to Parent -71.2M USD -25.2%
Earnings Per Share, Basic -1.22 USD/shares -9.91%
Earnings Per Share, Diluted -1.22 USD/shares -9.91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.93M USD -28.6%
Marketable Securities, Current 87.6M USD +9.38%
Assets, Current 98.7M USD +2.72%
Property, Plant and Equipment, Net 87K USD -26.9%
Operating Lease, Right-of-Use Asset 1.62M USD -24%
Assets 112M USD +9.65%
Accounts Payable, Current 3.15M USD -12.4%
Employee-related Liabilities, Current 3.98M USD +60.3%
Liabilities, Current 10.6M USD +32.5%
Operating Lease, Liability, Noncurrent 1.33M USD -32.5%
Liabilities 12.4M USD +19.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 64K USD
Retained Earnings (Accumulated Deficit) -361M USD -24.6%
Stockholders' Equity Attributable to Parent 99.6M USD +8.57%
Liabilities and Equity 112M USD +9.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16M USD -51.3%
Net Cash Provided by (Used in) Financing Activities 5.5M USD
Net Cash Provided by (Used in) Investing Activities -49.4M USD -1996%
Common Stock, Shares Authorized 165M shares +65%
Common Stock, Shares, Issued 60.5M shares +52.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59.9M USD -651%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.93M USD -28.6%
Deferred Tax Assets, Valuation Allowance 69.8M USD +17.9%
Deferred Tax Assets, Gross 70.3M USD +17.6%
Operating Lease, Liability 1.93M USD -23.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -71M USD -24.9%
Lessee, Operating Lease, Liability, to be Paid 2.12M USD -25.8%
Property, Plant and Equipment, Gross 210K USD 0%
Operating Lease, Liability, Current 599K USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 750K USD -2.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 770K USD +2.94%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 190K USD -45.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 750K USD +16.1%
Deferred Tax Assets, Operating Loss Carryforwards 38.9M USD -3.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 400K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 666K USD
Operating Lease, Payments 184K USD +7.6%
Additional Paid in Capital 460M USD +20.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 526K USD -8.52%
Share-based Payment Arrangement, Expense 6.52M USD -11.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%